1989
DOI: 10.1016/0165-1781(89)90081-4
|View full text |Cite
|
Sign up to set email alerts
|

Right hemisphere involvement in mescaline-induced psychosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1989
1989
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…Developmental processes are assumed to be dependent on genetic as well as prenatal and early-postnatal influences [33]. Moreover, psychotic episodes in turn lead to decreased or reversed functional hemispheric asymmetries [25,31,32]. Consequently, there may be an interaction of developmental and psychotic-related deviations in interhemispheric asymmetries [8].…”
Section: Discussionmentioning
confidence: 98%
“…Developmental processes are assumed to be dependent on genetic as well as prenatal and early-postnatal influences [33]. Moreover, psychotic episodes in turn lead to decreased or reversed functional hemispheric asymmetries [25,31,32]. Consequently, there may be an interaction of developmental and psychotic-related deviations in interhemispheric asymmetries [8].…”
Section: Discussionmentioning
confidence: 98%
“…Thus, clinical studies with mescaline attempting to better understand the “hallucinating state” and/or the basis of psychosis in normal subjects and psychiatric patients were subsequently carried out with valuable results, , prompting the controversial idea of using this drug as a tool to study the molecular and clinical nature of psychosis. This received moderate attention during the ensuing decades and has been reviewed recently, now as an alternative for the development of more effective strategies to treat schizophrenia. , Indeed, some evidence is consistent with the notion that an acute psychedelic experience with mescaline may be similar to acute schizophrenia, involving striato-limbic hyperactivity in the right brain hemisphere. Involvement of the right hemisphere plus frontal lobe hyperactivity was later confirmed in normal volunteers after mescaline ingestion . Early experimental evidence obtained in rodents demonstrated that mescaline possesses a mixed serotonergic and dopaminergic mechanism of action, as standard psychomotor responses in rodents could be blocked administering either methysergide or haloperidol, and actions on serotonergic and dopaminergic receptors were implicated. , Nevertheless, work performed in rodents further demonstrated the involvement of 5-HT 2 receptors in eliciting the psychotropic effects of mescaline, as shown by drug discrimination studies .…”
Section: Pharmacology and Structure–activity Relationshipsmentioning
confidence: 92%
“…The accidental finding regarding the hallucinogenic effects of a synthesized substance, D-Lysergic acid diethylamide (LSD), by a chemist named Albert Hoffman, and the later discovery (1948) of serotonin in bovine blood serum [11], helped to elucidate that these hallucinogens stimulate serotoninergic receptors (5-HT) in frontal cortical neurons [74]. Studies with mescaline are few in number, but it is known that its effects are accompanied by a "hyperfrontal pattern of increased blood flow", which correlates to mescaline-induced psychological effects [75,76]. A common effect of hallucinogenic compounds is the sensitization of serotonin and norepinephrine receptors.…”
Section: Mescaline and Nn-dimethyl Tryptaminementioning
confidence: 99%